Table 2.

Data analysis

Percentage of answers in the zones
0	1-3	4-6	7-9
< 20%	-	< 50%	≥ 50%	→ First-line treatment/strategy
< 20%	< 50%	≥ 50% and < 100%		→ Second-line treatment/strategy
< 20%	-	< 50%		→ Third-line treatment/strategy
≥ 50%	-	-	-	→ Contraindication

For all other cases (-), the question was considered as non-consensual.

The following rules were used to conclude the analyzed therapeutic strategy.